Stock market news: Relmada Therapeutics plunged by 75.54% while Cyclerion Therapeutics surged by 280.12% during mid day trading
Relmada Therapeutics, Inc. saw a significant drop of −75.54%, with shares priced at 0.68 USD and a market cap of 83.58 M USD.